title: Lenalidomide is effective for the treatment of bortezomib-resistant extramedullary disease in patients with multiple myeloma: report of 2 cases.
authors.affiliation: Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Japan.
authors.forename: Chisako
authors.initials: C
authors.lastname: Ito
authors.forename: Yoshinobu
authors.initials: Y
authors.lastname: Aisa
authors.forename: Ai
authors.initials: A
authors.lastname: Mihara
authors.forename: Tomonori
authors.initials: T
authors.lastname: Nakazato
mesh_terms: D000368:Aged; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D003907:Dexamethasone / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011719:Pyrazines / Q000627:therapeutic use*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib; D003907:Dexamethasone; D000077269:Lenalidomide